Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China · Delayed Price · Currency is CNY 11.16
+0.06 (0.54%)
Apr 30, 2026, 3:04 PM CST
SHE:000590 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -41.07 | -50.52 | -125.47 | 25.25 | 18.11 | 35.44 |
Depreciation & Amortization | 31.54 | 31.54 | 29.21 | 28.04 | 24.36 | 19.48 |
Other Amortization | 2.26 | 2.26 | 0.89 | 1.1 | 0.97 | 1.2 |
Loss (Gain) From Sale of Assets | -2.42 | -2.42 | -0 | -13.33 | -0.02 | -0.51 |
Asset Writedown & Restructuring Costs | 24.92 | 24.92 | 118.71 | 5.59 | 0.67 | 2.02 |
Loss (Gain) From Sale of Investments | -0.78 | -0.78 | 0.5 | -2.79 | -2.77 | -3.33 |
Provision & Write-off of Bad Debts | -0.18 | -0.18 | 0.25 | - | - | - |
Other Operating Activities | 32.41 | 11.9 | 29.35 | 4.99 | 2.07 | -1.86 |
Change in Accounts Receivable | 38.52 | 38.52 | -4.29 | -45.83 | 2.92 | -26.83 |
Change in Inventory | 14.46 | 14.46 | 5.13 | -11.64 | -7.33 | -35.57 |
Change in Accounts Payable | -34.32 | -34.32 | -32.03 | -28.32 | 15.52 | 35.66 |
Change in Other Net Operating Assets | -0.38 | -0.38 | - | 7.96 | -0.98 | -0.1 |
Operating Cash Flow | 58.91 | 28.96 | 17.39 | -29.39 | 54.47 | 25.2 |
Operating Cash Flow Growth | 905.77% | 66.54% | - | - | 116.20% | -51.06% |
Capital Expenditures | -50.46 | -48.81 | -32.1 | -22.04 | -18.68 | -25.88 |
Sale of Property, Plant & Equipment | 2.45 | 0.13 | 0.01 | 0.2 | 2.67 | 0.71 |
Cash Acquisitions | - | - | - | - | -214.52 | - |
Investment in Securities | -43 | - | - | 25 | 50 | -94 |
Other Investing Activities | 60.43 | 60.3 | 0.54 | 0.99 | 2.99 | 3.18 |
Investing Cash Flow | -30.58 | 11.62 | -31.55 | 4.15 | -177.54 | -115.98 |
Short-Term Debt Issued | - | 6 | - | - | - | - |
Long-Term Debt Issued | - | 48.68 | 38.11 | 20 | 130.8 | 0.05 |
Total Debt Issued | 21.63 | 54.68 | 38.11 | 20 | 130.8 | 0.05 |
Short-Term Debt Repaid | - | -6 | - | - | - | - |
Long-Term Debt Repaid | - | -75.09 | -38.22 | -48.13 | -20.94 | -7.79 |
Total Debt Repaid | -81.09 | -81.09 | -38.22 | -48.13 | -20.94 | -7.79 |
Net Debt Issued (Repaid) | -59.47 | -26.41 | -0.11 | -28.13 | 109.86 | -7.74 |
Issuance of Common Stock | - | - | 0.03 | - | - | - |
Common Dividends Paid | -2.99 | -3.35 | -3.47 | -4.2 | -0.34 | -0.06 |
Other Financing Activities | -2.08 | -1.4 | 0.23 | 0.82 | 2 | 2 |
Financing Cash Flow | -64.54 | -31.17 | -3.31 | -31.51 | 111.52 | -5.81 |
Net Cash Flow | -36.21 | 9.41 | -17.47 | -56.75 | -11.55 | -96.59 |
Free Cash Flow | 8.45 | -19.85 | -14.71 | -51.43 | 35.79 | -0.68 |
Free Cash Flow Margin | 2.46% | -5.88% | -4.29% | -12.71% | 10.21% | -0.23% |
Free Cash Flow Per Share | 0.04 | -0.08 | -0.06 | -0.21 | 0.15 | -0.00 |
Cash Income Tax Paid | 42.77 | 46.31 | 36.36 | 52.07 | 32.68 | 32.78 |
Levered Free Cash Flow | 84.02 | 47.02 | -8.13 | -64.34 | 21.79 | -23.75 |
Unlevered Free Cash Flow | 86.14 | 49.13 | -5.84 | -61.55 | 22.52 | -23.45 |
Change in Working Capital | 12.23 | 12.23 | -36.05 | -78.24 | 11.08 | -27.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.